Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology
Link
http://link.springer.com/content/pdf/10.1007/BF02246543.pdf
Reference37 articles.
1. Affrime M, Reidenberg MM (1975) The protein binding of some drugs in plasma from patients with alcoholic liver disease. Eur J Clin Pharmacol 8:267–309
2. Andreasen F (1973) Protein binding of drugs in plasma from patients with acute renal failure. Acta Pharmacol Toxicol 32:417–429
3. Barre J, Houin G, Rosenbaum J, Zini R, Dhumaux D, Tillement J-P (1984) Decreased alpha-1-acid glycoprotein in liver cirrhosis: consequences for drug protein binding. Br J Clin Pharmacol 18:652–653
4. Brøsen K, Gram LF (1989) Clinical significance of the sparteine/debrisoquine oxidation polymorphism. Eur J Clin Pharmacol 36:537–547
5. Claus A, Bollen J, De Cuyper H, Eneman M, Malfroid M, Peuskens J, Heylen S (1992) Risperidone versus haloperidol in the treatment of chronic schizofrenic inpatients: a multicentre double-blind comparative study. Acta Psychiat Scand 85:295–305
Cited by 110 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of a population pharmacokinetic model for the novel long‐acting injectable antipsychotic risperidone ISM®;British Journal of Clinical Pharmacology;2024-06-12
2. Re‐discover the value of protein binding assessments in hepatic and renal impairment studies and its contributions in drug labels and dose decisions;Clinical and Translational Science;2024-05
3. Factors influencing concentrations of risperidone and 9‐hydroxyrisperidone in psychiatric outpatients taking immediate‐release formulations of risperidone;Human Psychopharmacology: Clinical and Experimental;2023-11-20
4. (202) Use of Long-Acting Injectable Paliperidone to Increase Medication Compliance in Individuals with ESRD and Schizophrenia;Journal of the Academy of Consultation-Liaison Psychiatry;2023-11
5. Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring;British Journal of Clinical Pharmacology;2023-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3